Topics

Latest "MEDICREA" News Stories

01:16 EDT 21st September 2019 | BioPortfolio

Here are the most relevant search results for "MEDICREA" found in our extensive news archives from over 250 global news sources.

More Information about MEDICREA on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about MEDICREA for you to read. Along with our medical data and news we also list MEDICREA Clinical Trials, which are updated daily. BioPortfolio also has a large database of MEDICREA Companies for you to search.

Showing "MEDICREA" News Articles, all 13

Extremely Relevant

MEDICREA secures FDA approval for TULIP GENESIS solution

MEDICREA has received FDA Clearance for its TULIP GENESIS which completes its UNiD Adaptive Spine Intelligence (ASI) platform technology. MEDICREA aims at digital transformation of spinal surgery through The post MEDICREA secures FDA approval for TULIP GENESIS solution appeared first on NS Medical Devices.


Relevant

FDA clears Medicrea's Tulip Genesis screw device

Medicrea's Tulip Genesis top-loading screw device received approval from the FDA, completing the company's UNiD adaptive spin -More- 

Medicrea gets 3 US patents for AI spine surgery software platform

Medicrea has obtained three additional US patents for its UNID Adaptive Spine Intelligence software platform, which enables t -More- 


MEDICREA secures new patents to protect its UNiD ASI technology

The company pioneers the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI (Adaptive Spine Intelligence) proprietary software platform, services The post MEDICREA secures new patents to protect its UNiD ASI technology appeared first on NS Medical Devices.

MEDICREA® Secures Several New Patents to Protect its Proprietary platform technology UNiD ASI

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD® ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announced today that...

MEDICREA® Announces FDA Clearance of TULIP GENESIS to Complete its UNiDTM ASI platform technology

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the digital transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announced today that it has received FDA-Clearance ...

Medicrea Reports First Quarter 2019 Sales

STRONG GROWTH IN UNID® PATIENT-SPECIFIC SURGERIES IN THE USA: +68% WW SALES INCREASED BY 10% IN Q1 (+6% at constant exchange rate) USA SALES INCREASED BY 15% IN Q1 (+8% at constant exchange rate) STRENGTHENING OF MEDICREA PRODUCTS PORTFOLIO WITH PENDING FDA APPROVAL FOR A NEW THORACO-LUMBAR FIXATION SYSTEM ...

Medicrea Hosts Second Annual Meeting Focused on Artificial Intelligence and Analytics in New York, USA

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED ; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI™ (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announced today th...

Medicrea Reports First Half 2019 Sales

4,000 UNiD™ Patient-specific Surgeries Milestone Achieved as of June 30th, 2019 Worldwide Sales Increased by 10% (+6% at Constant Exchange Rate) on a Comparable Basis USA Sales Increased by +15% (+7% at Constant Exchange Rate) The Medicrea Group (Euronext Growth Paris - FR0004178572 - ALMED; OTCQX Best Market – MRNTF), pioneering the digital transformation of spinal surgery through...

MEDICREA® Enhances Its Proprietary UNiD ASI™ Service Platform with the Addition of an FDA-Cleared Device Planning and Selection Service

The MEDICREA® Group (Euronext Growth Paris: FR0004178572 – ALMED; OTCQX Best Market – MRNTF), pioneering the transformation of spinal surgery through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD ASI™ (Adaptive Spine Intelligence) proprietary software platform, services and technologies, announced today tha...

Medicrea Reports 2018 Annual Results

2018 Annual Sales: € 32.3M, +22% at Constant Exchange RateStrong Growth of UNiD® Surgeries in the USA: +67%Gross Margin Jumping to 77% in the 4th QuarterEBITDA at Break-Even in H2 2018Positive EBITDA Expected for 2019 A Unique Model in Patient-Specific Spine Surgery Based on Artificial Intelligence and Large Industrial Capacity The M...

Medicrea Reports First Half 2019 Financial Results

ACCELERATION OF THE NUMBER OF UNiD™ SURGERIES PERFORMED IN THE UNITED STATES: +48% SIGNIFICANT IMPROVEMENT IN GROSS MARGIN UP 9 POINTS AT 77% POSITIVE EBITDA (1) REDUCTION OF OPERATING LOSS BY €1.1M OBJECTIVE OF 5,000 UNiD™ SURGERIES ON A CUMULATIVE BASIS BY END OF 2019 CONFIRMED The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneer...

Medicrea Reports First Quarter 2019 Financial Results

Significant Improvement in Gross Margin Up 7 Points at 78% Positive Ebitda (1) Tight Control Over Operating Expense Reduction of Operating Loss The Medicrea Group (Euronext Growth Paris: FR0004178572-ALMED ; OTCQX Best Market –MRNTF), pioneering the transformation of spinal surgery t...


Quick Search

News Quicklinks